Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...
Reports Q4 revenue $11.40B, consensus $11.28B. “We finished 2024 with excellent financial performance, delivering strong growth on the top and ...
Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2024 results , with sales up 4.7% year on year to $11.4 billion.
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to ...
(a) Adjusted results in 2024 and 2023 exclude charges for inventory write-downs associated with large-scale abandonment of product lines, accelerated depreciation on manufacturing assets to be ...
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Thermo Fisher Scientific (TMO), which ...
Citi analyst Patrick B Donnelly maintained a Hold rating on Thermo Fisher (TMO – Research Report) yesterday and set a price target of ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the fourth quarter and full year ended December 31, 2024.